Loading clinical trials...
Loading clinical trials...
Breathing Low Oxygen to Enhance Spinal Stimulation Training and Functional Recovery in Persons With Chronic SCI: The BO2ST Trial
The purpose of this study is to determine how combining bouts of low oxygen, transcutaneous spinal cord stimulation, and walking training may improve walking function for people with chronic spinal cord injury.
The goal of the study is to determine whether repeatedly breathing mild bouts of low oxygen for brief periods (termed acute intermittent hypoxia (AIH)) combined with transcutaneous spinal cord stimulation (tSTIM) improves recovery of walking and strength after spinal cord injury. This idea stems from animal studies on respiration, in which investigators showed that mild AIH improves breathing in rats with spinal injuries as well as studies involving spinal cord stimulation. These studies showed that AIH induces plasticity, strengthening neural connections by increasing the production of key proteins and improving the sensitivity of spinal cord circuitry. Additional studies have shown that tSTIM may enhance function and strength for people with spinal cord injuries. The ultimate goal of this research is to assess if combining AIH and tSTIM with walking training can enhance individuals walking training greater than just AIH or tSTIM. By using low oxygen as a pre-treatment to tSTIM during walking training, functional independence and quality of life for servicemen and civilians may improve.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Shirley Ryan AbilityLab
Chicago, Illinois, United States
Spaulding Rehabilitation Hospital
Cambridge, Massachusetts, United States
Start Date
January 17, 2023
Primary Completion Date
October 1, 2026
Completion Date
December 1, 2026
Last Updated
March 20, 2026
60
ESTIMATED participants
Daily acute intermittent hypoxia
OTHER
Room air (SHAM)
OTHER
Walking + tSTIM
OTHER
Walking + Sham transcutaneous spinal stimulation (tSHAM)
OTHER
Lead Sponsor
Spaulding Rehabilitation Hospital
Collaborators
NCT06521723
NCT07386522
NCT07210411
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions